[144] ORACLE CORP SEC Filing

Rhea-AI Filing Summary

Oracle Corp (ORCL) filed a Form 144 notifying of a proposed sale of 3,500 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $1,077,510 and approximately 2,841,714,000 shares outstanding. The notice lists acquisitions by the selling person as compensation: 3,303 shares acquired on 06/01/2023 and 4,866 shares acquired on 06/01/2022. The filer reports no sales in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Regulatory compliance: The filer provided the required Rule 144 disclosure detailing broker, share amount, and acquisition history.
• Transparency: The filing states there were no sales in the past three months, clarifying aggregation considerations under Rule 144.

Negative

• Insider sale proposed: The notice documents a planned sale of 3,500 shares valued at $1,077,510, which could be perceived negatively by some investors despite likely immateriality.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for a small planned sale; unlikely to be material to ORCL shareholders.

The Form 144 documents a proposed sale of 3,500 common shares via J.P. Morgan with an indicated aggregate market value of $1,077,510. Given the issuer's large share count (2.84 billion outstanding), this transaction appears immaterial to the companys capital structure. The filing confirms the shares were acquired as compensation in 2022 and 2023 and that there were no sales in the prior three months, consistent with Rule 144 aggregation requirements. No financial results, litigation, or other operational disclosures are included.

Corporate Governance Expert

TL;DR: Procedural compliance with Rule 144; disclosure provides transparency but does not indicate corporate governance events.

The notice fulfills the regulatory requirement to disclose proposed off-exchange insider sales and sources of acquisition (compensation). The signature representation that the seller is unaware of undisclosed material adverse information is standard. The filing contains no information about any trading plan adoption date or off-schedule transfers. From a governance perspective, this is a routine disclosure rather than a signal of management change or material event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 390 Madison Avenue - 6th Floor New York NY 10017	3500	1077510	2841714000	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2023	Compensation	Issuer			3303	06/01/2023	N/A
Common	06/01/2022	Compensation	Issuer			4866	06/01/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Oracle (ORCL) report in the Form 144 filing?

The filing notifies a proposed sale of 3,500 common shares via J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $1,077,510.

When is the approximate date of the proposed sale in the ORCL Form 144?

The approximate date of sale is listed as 09/12/2025.

How were the shares being sold originally acquired according to the filing?

The shares were acquired as compensation: 3,303 shares on 06/01/2023 and 4,866 shares on 06/01/2022.

Does the Form 144 report any sales in the past three months for the seller?

No. The filing states Nothing to Report for securities sold during the past three months.

Which broker is handling the proposed sale in the ORCL filing?

The broker named is J.P. Morgan Securities LLC with an address at 390 Madison Avenue, New York, NY.